Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility lociCatharine West, Fredrick R. Schumacher, Ali Amin Al Olama et al.|Nature Genetics|2018Cited by 1k
Intermittent versus Continuous Androgen Deprivation in Prostate CancerMaha Hussain, Ian M. Thompson, Ulka N. Vaishampayan et al.|New England Journal of Medicine|2013Cited by 568
Computer-Aided Prostate Cancer Diagnosis From Digitized Histopathology: A Review on Texture-Based SystemsClara Mosquera-Lopez, Ian M. Thompson, Sos С. Agaian et al.|IEEE Reviews in Biomedical Engineering|2014Cited by 118
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variantsTokhir Dadaev, Lorelei A. Mucci, Edward J. Saunders et al.|Nature Communications|2018Cited by 113
Parallel (Randomized) Phase II Evaluation of Tivantinib (ARQ197) and Tivantinib in Combination with Erlotinib in Papillary Renal Cell Carcinoma: SWOG S1107Przemyslaw Twardowski, Primo N. Lara, Catherine M. Tangen et al.|Kidney Cancer|2017Cited by 41